Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Sadr Ahmad — Apellis Pharmaceuticals, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Sadr Ahmad

Sadr Ahmad

See Remarks at Apellis Pharmaceuticals, Inc. · on record since Apr 15, 2019

Insider trading activity of Sadr Ahmad

Transactions on record: 2; since Feb 12, 2020

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 12, 2020

Figures computed from official regulatory filings — methodology.

Companies where Sadr Ahmad has traded

Apellis Pharmaceuticals, Inc.2 tx · Feb 12, 2020

Track record of Sadr Ahmad

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Sadr Ahmad

Co-insiders of Sadr Ahmad

AJU IB Investment Co., Ltd.Apellis Pharmaceuticals, Inc.
Axon StevenApellis Pharmaceuticals, Inc.
Baumal CarolineApellis Pharmaceuticals, Inc.
BIOGEN IDEC INCApellis Pharmaceuticals, Inc.
Boucher KelleyApellis Pharmaceuticals, Inc.
Brown Victoria L.Apellis Pharmaceuticals, Inc.
Celona LuciaApellis Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Chan GeraldApellis Pharmaceuticals, Inc.

Chen BihuaApellis Pharmaceuticals, Inc.

Chopas James GeorgeApellis Pharmaceuticals, Inc.

Cormorant Asset Management, LPApellis Pharmaceuticals, Inc.

Cormorant Global Healthcare GP, LLCApellis Pharmaceuticals, Inc.

Cormorant Global Healthcare Master Fund, LPApellis Pharmaceuticals, Inc.

CORMORANT PRIVATE HEALTHCARE FUND I, LPApellis Pharmaceuticals, Inc.

DeLong Mark JeffreyApellis Pharmaceuticals, Inc.

Deschatelets PascalApellis Pharmaceuticals, Inc.

Dolsten MikaelApellis Pharmaceuticals, Inc.

Dunlop A. SinclairApellis Pharmaceuticals, Inc.

Eisele JeffreyApellis Pharmaceuticals, Inc.

FONTEYNE PAUL R.Apellis Pharmaceuticals, Inc.

Francois CedricApellis Pharmaceuticals, Inc.

GELLERT MICHAEL EApellis Pharmaceuticals, Inc.

Grossi FedericoApellis Pharmaceuticals, Inc.

Hillhouse Capital Management, Ltd.Apellis Pharmaceuticals, Inc.

Lackner Thomas A.Apellis Pharmaceuticals, Inc.

Lewis KarenApellis Pharmaceuticals, Inc.

Machiels AlecApellis Pharmaceuticals, Inc.

MELTZER LESLIEApellis Pharmaceuticals, Inc.

Morningside Venture Investments LtdApellis Pharmaceuticals, Inc.

Nicholson NurApellis Pharmaceuticals, Inc.

O'Brien Stephanie MonaghanApellis Pharmaceuticals, Inc.

Perry Nicole DApellis Pharmaceuticals, Inc.

Potentia Holdings, LLCApellis Pharmaceuticals, Inc.

SCHEIBLER LUKASApellis Pharmaceuticals, Inc.

Sullivan Timothy EugeneApellis Pharmaceuticals, Inc.

Townsend Adam J.Apellis Pharmaceuticals, Inc.

venBio Global Strategic Fund II L.P.Apellis Pharmaceuticals, Inc.

Walbert KeliApellis Pharmaceuticals, Inc.

Watson David O.Apellis Pharmaceuticals, Inc.

WHEELER CRAIG AApellis Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Apellis Pharmaceuticals, Inc.	Feb 12, 2020	Award	2,725	0.00 USD	$0	SEC
Apellis Pharmaceuticals, Inc.	Feb 12, 2020	AwardD	16,350	0.00 USD	$0	SEC